Suppr超能文献

穿透性角膜移植术后二期人工晶状体植入技术的比较。

Comparison of the Techniques of Secondary Intraocular Lens Implantation after Penetrating Keratoplasty.

作者信息

Krysik Katarzyna, Dobrowolski Dariusz, Wroblewska-Czajka Ewa, Lyssek-Boron Anita, Wylegala Edward

机构信息

Department of Ophthalmology with Paediatric Unit, St. Barbara Hospital, Trauma Center, Medykow Square 1, 41-200 Sosnowiec, Poland.

Chair and Clinical Department of Ophthalmology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Panewnicka 65 St., 40-760 Katowice, Poland.

出版信息

J Ophthalmol. 2018 Sep 12;2018:3271017. doi: 10.1155/2018/3271017. eCollection 2018.

Abstract

AIM

To conduct a retrospective analysis of secondary IOL implantation in patients who underwent PK with no simultaneous IOL implantation.

MATERIALS AND METHODS

The retrospective study of the secondary implantation of IOLs was conducted in 46 eyes that underwent a primary operation with PK and cataract/lens extraction with no IOL implantation due to capsule rupture or combining corneal or intraocular complications. The minimum period from PK was 12 months. All secondary IOL implantations were performed from January 2011 to August 2017. Aphakic postkeratoplasty patients were treated using one of the surgical techniques for secondary IOL implantation. In-the-bag IOL implantation was possible if the posterior capsule was complete. If the lens capsule remnants were sufficient to provide secure IOL support, an in-the-sulcus IOL implantation was performed. Scleral fixation was offered in eyes with extensive capsular deficiency or the presence of the vitreous body in anterior chamber. BCVA and expected and achieved refraction were evaluated; we included using two biometry devices, and results were compared.

RESULTS

The corrected distance visual acuity (CDVA) before surgery ranged from 0.1 to 0.8 (mean 0.54 ± 0.17). After secondary IOL implantation, CDVA ranged from 0.2 to 0.8 (mean 0.43 ± 0.14) at postoperative 1 month and from 0.3 to 0.9 (mean 0.55 ± 0.15) at postoperative 6 months ( < 0.05). Comparison of the final refraction using two methods of biometry showed no statistically significant difference in the group that underwent scleral fixation of the IOL, similar to the findings for the in-the-bag and in-the-sulcus IOL implantation groups. In the scleral-fixation group, =0.55 for the USG biometry technique and =0.22 for the OB technique. values for the IOL-implantation group were =0.49 and =0.44, respectively.

CONCLUSION

Both implantation methods are safe for the patients. Final refraction is depending on the technique and indication to keratoplasty. Both biometry techniques deliver precise data for IOL choice.

摘要

目的

对接受穿透性角膜移植术(PK)且未同期植入人工晶状体(IOL)的患者进行二期IOL植入的回顾性分析。

材料与方法

对46只眼进行IOL二期植入的回顾性研究,这些眼睛因囊膜破裂或合并角膜或眼内并发症,在初次PK联合白内障/晶状体摘除手术中未植入IOL。距PK的最短时间为12个月。所有二期IOL植入均在2011年1月至2017年8月期间进行。无晶状体角膜移植术后患者采用二期IOL植入的手术技术之一进行治疗。如果后囊完整,则可行囊袋内IOL植入。如果晶状体囊膜残余足以提供牢固的IOL支撑,则进行睫状沟内IOL植入。对于存在广泛囊膜缺损或前房有玻璃体的眼睛,采用巩膜固定术。评估最佳矫正视力(BCVA)以及预期和实际屈光情况;我们使用两种生物测量设备并比较结果。

结果

手术前矫正远视力(CDVA)范围为0.1至0.8(平均0.54±0.17)。二期IOL植入后,术后1个月CDVA范围为0.2至0.8(平均0.43±0.14),术后6个月为0.3至0.9(平均0.55±0.15)(P<0.05)。使用两种生物测量方法对最终屈光情况进行比较,结果显示IOL巩膜固定组无统计学显著差异,与囊袋内和睫状沟内IOL植入组的结果相似。在巩膜固定组中,超声生物测量技术的r值为0.55,光学相干生物测量技术的r值为0.22。IOL植入组的r值分别为0.49和0.44。

结论

两种植入方法对患者均安全。最终屈光情况取决于技术和角膜移植的适应证。两种生物测量技术均可为IOL选择提供精确数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c619/6157166/f71aa7b784c3/JOPH2018-3271017.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验